BioNexus Gene Lab Corp

Except as stated herein, there are presently no legal proceedings filed to date to which the Company or any of its property is subject, or any material proceedings to which any director, officer or affiliate of the Company, any owner of record or beneficially of more than five percent of any class of voting securities is a party or has a material interest adverse to the Company, and no such proceedings are known to the Company to be threatened or contemplated against it.

As disclosed elsewhere herein, on May 13, 2026, the Company issued Letters of Demand to the five former officers and directors of Chemrex demanding that the former officers and directors repay to Chemrex the collective sum of approximately $2,944,000 within 14 days. The former officers and directors paid these amounts to themselves from the Chemrex corporate account during the period from July 2024 through August 2025. The Company’s position is these amounts now demanded for repayment were unauthorized transactions under Malaysian law. The Company continues its investigation into the activities of these parties as it relates to the negative impact on the business of Chemrex. The Company intends to avail itself of all claims and demands against these parties related to this issue and potentially other matters.